STOCKSCREENR
Log In

VTRS

NASDAQ

Viatris Inc.

$13.80+0.29(+2.15%)Mkt Cap: $15.89B

Key Stats

Market Cap

$15.89B

P/E Ratio

-4.60

EPS

$-3.00

Dividend Yield

3.39%

52-Week Range

$6.85 — $16.47

Volume

11.11M

Avg Volume

10.39M

Beta

0.80

Valuation

P/E (TTM)

-4.60

Forward P/E

5.61

PEG Ratio

-1.10

P/S (TTM)

1.14

P/B (TTM)

1.11

P/FCF

17.87

EV/EBITDA

31.58x

EV/Sales

—

Financial Health

ROE (TTM)

-0.23%

ROA (TTM)

-0.09%

ROIC

0.01%

Gross Margin

0.35%

Operating Margin

-0.19%

Net Margin

-0.03%

Debt/Equity

1.00

Current Ratio

1.38

Growth

EPS Growth (YoY)

-2.39%

Revenue Growth (YoY)

+0.03%

EPS Growth (3Y)

—

EPS Growth (5Y)

—

Sales Growth (3Y)

—

Sales Growth (5Y)

—

EPS Est (This Year)

$2.46

EPS Est (Next Year)

$2.66

Dividends

Dividend Yield

—

Annual Dividend

$0.12

Payout Ratio

-1.09%

Frequency

—

Ex-Dividend Date

2025-11-24

Cash/Share

$1.26

Analyst Consensus

3.0

Hold

1 = Strong Buy, 5 = Strong Sell

Price Target Range

$12.00$15.50$18.00
LowMedianHigh

Consensus Target: $15.25(10.5% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

0

Outstanding Shares

1.15B

Float

1.14B

Free Float %

99.24%

Technicals

RSI (14)

92.51

SMA 20

$13.60

SMA 50

$12.52

SMA 200

$10.59

ATR (14)

0.41

Volatility (Week)

0.03%

Volatility (Month)

0.02%

Pattern

—

Performance

1 Day

+2.51%

1 Week

+16.59%

1 Month

+25.00%

3 Months

+57.61%

6 Months

+61.76%

1 Year

—

YTD

+28.01%

All-Time High

$16.04

About

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

US

Exchange

NASDAQ

IPO Date

1980-03-17

Employees

32000

CEO

Scott Andrew Smith

Index Membership

S&P 500

Website

https://www.viatris.com

Viatris Inc. (VTRS) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $15.89B, a P/E ratio of -4.60, and a dividend yield of 3.39%, VTRS is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare VTRS against other stocks using dozens of fundamental and technical filters.

Similar Stocks

INDV

Indivior Pharmaceuticals Inc

$31.33

+1.16%

$3.91B

AMRX

Amneal Pharmaceuticals, Inc.

$12.43

+4.10%

$3.91B

LNTH

Lantheus Holdings, Inc.

$80.45

+2.48%

$5.33B

HLN

Haleon plc

$10.60

+1.34%

$47.21B

TAK

Takeda Pharmaceutical Company Limited

$18.39

+0.93%

$58.10B

ZTS

Zoetis Inc.

$121.68

+2.99%

$53.62B

Frequently Asked Questions

What is Viatris Inc.'s P/E ratio?

Viatris Inc. (VTRS) has a trailing twelve-month (TTM) P/E ratio of -4.60. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Viatris Inc. pay a dividend?

No, Viatris Inc. (VTRS) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Viatris Inc.'s market cap?

Viatris Inc. (VTRS) has a market capitalization of $15.89 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

What do analysts think about VTRS?

Wall Street analysts have a consensus "Hold" rating on Viatris Inc. (VTRS) with an average score of 3.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $15.25 implies 10.5% upside from the current price.

How has VTRS performed this year?

Viatris Inc. (VTRS) has returned +28.01% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.